Giorgio Scalise

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Living Beings

Disorders

Phenomena

Drug Synergism

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Spreghini Elisabetta; Orlando Fiorenza; Santinelli Alfredo; Pisa Eleonora; Loretelli Cristian; Manso Esther; Milici Maria Eleonara; Scalise Giorgio; Barchiesi Francesco
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.
Barchiesi Francesco; Silvestri Carmela; Arzeni Daniela; Ganzetti Giulia; Castelletti Sefora; Simonetti Oriana; Cirioni Oscar; Kamysz Wojciech; Kamysz Elzbieta; Spreghini Elisabetta; Abruzzetti Alessandra; Riva Alessandra; Offidani Anna M; Giacometti Andrea; Scalise Giorgio
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Giorgio Scalise (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Peptides 2009;30(10):1794-7.
2009: Spreghini Elisabetta; Orlando Fiorenza; Santinelli Alfredo; Pisa Eleonora; Loretelli Cristian; Manso Esther; Milici Maria Eleonara; Scalise Giorgio; Barchiesi Francesco
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2009;53(9):4035-9.
2009: Barchiesi Francesco; Silvestri Carmela; Arzeni Daniela; Ganzetti Giulia; Castelletti Sefora; Simonetti Oriana; Cirioni Oscar; Kamysz Wojciech; Kamysz Elzbieta; Spreghini Elisabetta; Abruzzetti Alessandra; Riva Alessandra; Offidani Anna M; Giacometti Andrea; Scalise Giorgio
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47(3):321-6.
2009: Cirioni Oscar; Silvestri Carmela; Ghiselli Roberto; Orlando Fiorenza; Riva Alessandra; Gabrielli Eleonora; Mocchegiani Federico; Cianforlini Nancy; Trombettoni Maria Michela Cappelletti; Saba Vittorio; Scalise Giorgio; Giacometti Andrea
Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.
Critical care medicine 2009;37(4):1403-7.
2008: Maida Carmelo Massimo; Milici Maria Eleonora; Trovato Laura; Oliveri Salvatore; Amodio Emanuele; Spreghini Elisabetta; Scalise Giorgio; Barchiesi Francesco
Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.
Journal of clinical microbiology 2008;46(12):4071-4.
2008: Cirioni Oscar; Silvestri Carmela; Ghiselli Roberto; Orlando Fiorenza; Riva Alessandra; Mocchegiani Federico; Chiodi Leonardo; Castelletti Sefora; Gabrielli Eleonora; Saba Vittorio; Scalise Giorgio; Giacometti Andrea
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
The Journal of antimicrobial chemotherapy 2008;62(6):1332-8.
2008: Cirioni Oscar; Ghiselli Roberto; Silvestri Carmela; Kamysz Wojciech; Orlando Fiorenza; Riva Alessandra; Kamysz Elzbieta; Castelletti Sefora; Rocchi Marco; Saba Vittorio; Scalise Giorgio; Giacometti Andrea
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
Antimicrobial agents and chemotherapy 2008;52(12):4351-5.
2008: Cirioni Oscar; Ghiselli Roberto; Tomasinsig Linda; Orlando Fiorenza; Silvestri Carmela; Skerlavaj Barbara; Riva Alessandra; Rocchi Marco; Saba Vittorio; Zanetti Margherita; Scalise Giorgio; Giacometti Andrea
Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.
Shock (Augusta, Ga.) 2008;30(4):443-8.
2008: Cirioni Oscar; Ghiselli Roberto; Orlando Fiorenza; Silvestri Carmela; De Luca Stefania; Salzano Anna Maria; Mocchegiani Federico; Saba Vittorio; Scalise Giorgio; Scaloni Andrea; Giacometti Andrea
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
Critical care medicine 2008;36(9):2629-33.
2008: Dalla Serra Mauro; Cirioni Oscar; Vitale Rosa Maria; Renzone Giovanni; Coraiola Manuela; Giacometti Andrea; Potrich Cristina; Baroni Elisa; Guella Graziano; Sanseverino Marina; De Luca Stefania; Scalise Giorgio; Amodeo Pietro; Scaloni Andrea
Structural features of distinctin affecting peptide biological and biochemical properties.
Biochemistry 2008;47(30):7888-99.
2008: Orlando Fiorenza; Ghiselli Roberto; Cirioni Oscar; Minardi Daniele; Tomasinsig Linda; Mocchegiani Federico; Silvestri Carmela; Skerlavaj Barbara; Riva Alessandra; Muzzonigro Giovanni; Saba Vittorio; Scalise Giorgio; Zanetti Margherita; Giacometti Andrea
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
Peptides 2008;29(7):1118-23.
2008: Simonetti Oriana; Cirioni Oscar; Ghiselli Roberto; Goteri Gaia; Scalise Alessandro; Orlando Fiorenza; Silvestri Carmela; Riva Alessandra; Saba Vittorio; Madanahally Kiran D; Offidani Annamaria; Balaban Naomi; Scalise Giorgio; Giacometti Andrea
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2008;52(6):2205-11.
2008: Spreghini Elisabetta; Maida Carmelo Massimo; Tomassetti Serena; Orlando Fiorenza; Giannini Daniele; Milici Maria Eleonora; Scalise Giorgio; Barchiesi Francesco
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
Antimicrobial agents and chemotherapy 2008;52(6):1929-33.
2008: Simonetti Oriana; Cirioni Oscar; Goteri Gaia; Ghiselli Roberto; Kamysz Wojciech; Kamysz Elzbieta; Silvestri Carmela; Orlando Fiorenza; Barucca Claudia; Scalise Alessandro; Saba Vittorio; Scalise Giorgio; Giacometti Andrea; Offidani Annamaria
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model.
Peptides 2008;29(4):520-8.
2008: Spreghini Elisabetta; Maida Carmelo Massimo; Milici Maria Eleonora; Scalise Giorgio; Barchiesi Francesco
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Antimicrobial agents and chemotherapy 2008;52(2):513-7.
2008: Ghiselli Roberto; Giacometti Andrea; Cirioni Oscar; Mocchegiani Federico; Orlando Fiorenza; Silvestri Carmela; Di Matteo Fabio; Abbruzzetti Alessandra; Scalise Giorgio; Saba Vittorio
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Critical care medicine 2008;36(1):240-5.
2008: Cirioni Oscar; Ghiselli Roberto; Kamysz Wojciech; Orlando Fiorenza; Silvestri Carmela; Mocchegiani Federico; Di Matteo Fabio; Kamysz Elzbieta; Riva Alessandra; Rocchi Marco; Saba Vittorio; Scalise Giorgio; Giacometti Andrea
Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Peptides 2008;29(1):31-8.
2008: Ghiselli Roberto; Cirioni Oscar; Giacometti Andrea; Scalise Alessandro; Simonetti Oriana; Mocchegiani Federico; Orlando Fiorenza; Goteri Gaia; Della Vittoria Agnese; Filosa Alessandra; Silvestri Carmela; Offidani Annamaria; Bertani Aldo; Scalise Giorgio; Saba Vittorio
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections.
The Journal of surgical research 2008;144(1):74-81.
2007: Minardi Daniele; Ghiselli Roberto; Cirioni Oscar; Giacometti Andrea; Kamysz Wojciech; Orlando Fiorenza; Silvestri Carmela; Parri Gianni; Kamysz Elzbieta; Scalise Giorgio; Saba Vittorio; Giovanni Muzzonigro
The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model.
Peptides 2007;28(12):2293-8.
2007: Cirioni Oscar; Ghiselli Roberto; Minardi Daniele; Orlando Fiorenza; Mocchegiani Federico; Silvestri Carmela; Muzzonigro Giovanni; Saba Vittorio; Scalise Giorgio; Balaban Naomi; Giacometti Andrea
RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.
Antimicrobial agents and chemotherapy 2007;51(12):4518-20.
2007: Ghiselli Roberto; Giacometti Andrea; Cirioni Oscar; Mocchegiani Federico; Silvestri Carmela; Orlando Fiorenza; Kamysz Wojciech; Licci Alberto; Nadolski Piotr; Della Vittoria Agnese; Lukasiak Jerzy; Scalise Giorgio; Saba Vittorio
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
JPEN. Journal of parenteral and enteral nutrition 2007;31(6):463-8.
2007: Milici Maria Eleonora; Maida Carmelo Massimo; Spreghini Elisabetta; Ravazzolo Barbara; Oliveri Salvatore; Scalise Giorgio; Barchiesi Francesco
Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.
Journal of clinical microbiology 2007;45(11):3529-33.
2007: Barchiesi F; Giacometti A; Cirioni O; Arzeni D; Kamysz W; Silvestri C; Licci A; Marigliano A; Della Vittoria A; Nadolski P; Lukasiak J; Scalise G
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.
Journal of chemotherapy (Florence, Italy) 2007;19(5):514-8.
2007: Barchiesi Francesco; Giacometti Andrea; Cirioni Oscar; Arzeni Daniela; Silvestri Carmela; Kamysz Wojciech; Abbruzzetti Alessandra; Riva Alessandra; Kamysz Elzbieta; Scalise Giorgio
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
Peptides 2007;28(8):1509-13.
2007: Marinelli Katia; Bagnarelli Patrizia; Gaffi Gianni; Trappolini Silvia; Leoni Pietro; Paggi Alessandra Mataloni; Della Vittoria Agnese; Scalise Giorgio; Varaldo Pietro Emanuele; Menzo Stefano
PCR real time assays for the early detection of BKV-DNA in immunocompromised patients.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2007;30(3):275-8.
2007: Cirioni Oscar; Ghiselli Roberto; Orlando Fiorenza; Silvestri Carmela; Mocchegiani Federico; Rocchi Marco; Chiodi Leonardo; Abbruzzetti Alessandra; Saba Vittorio; Scalise Giorgio; Giacometti Andrea
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
Critical care medicine 2007;35(7):1717-23.
2007: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Kamysz Wojciech; Silvestri Carmela; Orlando Fiorenza; Mocchegiani Federico; Vittoria Agnese Della; Kamysz Elzbieta; Saba Vittorio; Scalise Giorgio
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
Peptides 2007;28(6):1299-303.
2007: Cirioni Oscar; Giacometti Andrea; Kamysz Wojciech; Silvestri Carmela; Riva Alessandra; Della Vittoria Agnese; Abbruzzetti Alessandra; Lukasiak Jerzy; Scalise Giorgio
In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
Peptides 2007;28(4):747-51.
2007: Giacometti Andrea; Cirioni Oscar; Riva Alessandra; Kamysz Wojciech; Silvestri Carmela; Nadolski Piotr; Della Vittoria Agnese; Lukasiak Jerzy; Scalise Giorgio
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Antimicrobial agents and chemotherapy 2007;51(4):1494-6.
2007: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Orlando Fiorenza; Silvestri Carmela; Renzone Giovanni; Testa Irma; Mocchegiani Federico; Della Vittoria Agnese; Saba Vittorio; Scaloni Andrea; Scalise Giorgio
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection.
Journal of biomedical materials research. Part A 2007;81(1):233-9.
2007: Barchiesi Francesco; Spreghini Elisabetta; Tomassetti Serena; Giannini Daniele; Scalise Giorgio
Caspofungin in combination with amphotericin B against Candida parapsilosis.
Antimicrobial agents and chemotherapy 2007;51(3):941-5.
2007: Barchiesi F; Arzeni D; Greganti G; Marigliano A; Tomassetti S; Spreghini E; Scalise G
Fluconazole susceptibility of Candida spp. isolates collected over nine years in a teaching hospital of Ancona, Italy.
Journal of chemotherapy (Florence, Italy) 2007;19(1):58-61.
2007: Kamysz Wojciech; Silvestri Carmela; Cirioni Oscar; Giacometti Andrea; Licci Alberto; Della Vittoria Agnese; Okroj Marcin; Scalise Giorgio
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci.
Antimicrobial agents and chemotherapy 2007;51(1):354-8.
2007: Barchiesi Francesco; Spreghini Elisabetta; Santinelli Alfredo; Fothergill Annette W; Pisa Eleonora; Giannini Daniele; Rinaldi Michael G; Scalise Giorgio
Posaconazole prophylaxis in experimental systemic zygomycosis.
Antimicrobial agents and chemotherapy 2007;51(1):73-7.
2006: Cirioni Oscar; Giacometti Andrea; Silvestri Carmela; Della Vittoria Agnese; Licci Alberto; Riva Alessandra; Scalise Giorgio
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 2006;50(11):3923-5.
2006: Ghiselli Roberto; Cirioni Oscar; Giacometti Andrea; Mocchegiani Federico; Orlando Fiorenza; Bergnach Cristina; Skerlavaj Barbara; Silvestri Carmela; Vittoria Agnese Della; Zanetti Margherita; Rocchi Marco; Scalise Giorgio; Saba Vittorio
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide.
Peptides 2006;27(11):2592-9.
2006: Cirioni Oscar; Silvestri Carmela; Ghiselli Roberto; Giacometti Andrea; Orlando Fiorenza; Mocchegiani Federico; Chiodi Leonardo; Vittoria Agnese Della; Saba Vittorio; Scalise Giorgio
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
Peptides 2006;27(11):2600-6.
2006: Ghiselli Roberto; Giacometti Andrea; Cirioni Oscar; Dell'Acqua Giorgio; Bergnach Cristina; Orlando Fiorenza; Mocchegiani Federico; Silvestri Carmela; Skerlavaj Barbara; Licci Alberto; Balaban Naomi; Zanetti Margherita; Scalise Giorgio; Saba Vittorio
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Shock (Augusta, Ga.) 2006;26(3):296-301.
2006: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Mocchegiani Federico; Silvestri Carmela; Orlando Fiorenza; Kamysz Wojciech; Licci Alberto; Kamysz Elzbieta; Lukasiak Jerzy; Saba Vittorio; Scalise Giorgio
Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.
Critical care medicine 2006;34(9):2415-20.
2006: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Bergnach Cristina; Orlando Fiorenza; Mocchegiani Federico; Silvestri Carmela; Licci Alberto; Skerlavaj Barbara; Zanetti Margherita; Saba Vittorio; Scalise Giorgio
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection.
Peptides 2006;27(9):2104-10.
2006: Ghiselli Roberto; Cirioni Oscar; Giacometti Andrea; Mocchegiani Federico; Orlando Fiorenza; Silvestri Carmela; Licci Alberto; Della Vittoria Agnese; Scalise Giorgio; Saba Vittorio
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock.
Shock (Augusta, Ga.) 2006;26(2):195-200.
2006: Barchiesi Francesco; Spreghini Elisabetta; Tomassetti Serena; Della Vittoria Agnese; Arzeni Daniela; Manso Esther; Scalise Giorgio
Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
Antimicrobial agents and chemotherapy 2006;50(8):2719-27.
2006: Girmenia Corrado; Pizzarelli Giampaolo; Cristini Francesco; Barchiesi Francesco; Spreghini Elisabetta; Scalise Giorgio; Martino Pietro
Candida guilliermondii fungemia in patients with hematologic malignancies.
Journal of clinical microbiology 2006;44(7):2458-64.
2006: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Mocchegiani Federico; Orlando Fiorenza; Silvestri Carmela; Bozzi Argante; Di Giulio Antonio; Luzi Carla; Mangoni Maria Luisa; Barra Donatella; Saba Vittorio; Scalise Giorgio; Rinaldi Andrea C
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Antimicrobial agents and chemotherapy 2006;50(7):2478-86.
2006: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Kamysz Wojciech; Orlando Fiorenza; Mocchegiani Federico; Silvestri Carmela; Licci Alberto; Chiodi Leonardo; Lukasiak Jerzy; Saba Vittorio; Scalise Giorgio
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Peptides 2006;27(6):1210-6.
2006: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Bergnach Cristina; Orlando Fiorenza; Silvestri Carmela; Mocchegiani Federico; Licci Alberto; Skerlavaj Barbara; Rocchi Marco; Saba Vittorio; Zanetti Margherita; Scalise Giorgio
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
Antimicrobial agents and chemotherapy 2006;50(5):1672-9.
2006: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Dell'Acqua Giorgio; Orlando Fiorenza; Mocchegiani Federico; Silvestri Carmela; Licci Alberto; Saba Vittorio; Scalise Giorgio; Balaban Naomi
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
The Journal of infectious diseases 2006;193(2):180-6.
2006: Kamysz Wojciech; Nadolski Piotr; Kedzia Anna; Cirioni Oscar; Barchiesi Francesco; Giacometti Andrea; Scalise Giorgio; Lukasiak Jerzy; Okrój Marcin
In vitro activity of synthetic antimicrobial peptides against Candida.
Polish journal of microbiology / Polskie Towarzystwo Mikrobiologów = The Polish Society of Microbiologists 2006;55(4):303-7.
2005: Barchiesi Francesco; Spreghini Elisabetta; Santinelli Alfredo; Fothergill Annette W; Fallani Stefania; Manso Esther; Pisa Eleonora; Giannini Daniele; Novelli Andrea; Cassetta Maria I; Mazzei Teresita; Rinaldi Michael G; Scalise Giorgio
Efficacy of caspofungin against Aspergillus terreus.
Antimicrobial agents and chemotherapy 2005;49(12):5133-5.
2005: Barchiesi Francesco; Spreghini Elisabetta; Tomassetti Serena; Arzeni Daniela; Giannini Daniele; Scalise Giorgio
Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
Antimicrobial agents and chemotherapy 2005;49(12):4989-92.
2005: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; Silvestri Carmela; Licci Alberto; Riva Alessandro; Lukasiak Jerzy; Scalise Giorgio
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
Peptides 2005;26(11):2111-6.
2005: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Kamysz Wojciech; Orlando Fiorenza; Mocchegiani Federico; Silvestri Carmela; Licci Alberto; Lukasiak Jerzy; Saba Vittorio; Scalise Giorgio
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
The Journal of infectious diseases 2005;192(9):1613-20.
2005: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Orlando Fiorenza; Mocchegiani Federico; Silvestri Carmela; Licci Alberto; De Fusco Matteo; Provinciali Mauro; Saba Vittorio; Scalise Giorgio
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2005;49(10):4042-5.
2005: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; Silvestri Carmela; Licci Alberto; D'Amato Giuseppina; Nadolski Piotr; Riva Alessandra; Lukasiak Jerzy; Scalise Giorgio
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.
Antimicrobial agents and chemotherapy 2005;49(9):3933-6.
2005: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; D'Amato Giuseppina; Silvestri Carmela; Licci Alberto; Nadolski Piotr; Riva Alessandra; Lukasiak Jerzy; Scalise Giorgio
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
International journal of antimicrobial agents 2005;26(3):235-40.
2005: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; Silvestri Carmela; Del Prete Maria Simona; Licci Alberto; D'Amato Giuseppina; Lukasiak Jerzy; Scalise Giorgio
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
The Journal of antimicrobial chemotherapy 2005;56(2):410-2.
2005: Barchiesi F; Cogliati M; Esposto M C; Spreghini E; Schimizzi A M; Wickes B L; Scalise G; Viviani M A
Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.
The Journal of infection 2005;51(1):10-6.
2005: Barchiesi Francesco; Spreghini Elisabetta; Fothergill Annette W; Arzeni Daniela; Greganti Gianfranco; Giannini Daniele; Rinaldi Michael G; Scalise Giorgio
Caspofungin in combination with amphotericin B against Candida glabrata.
Antimicrobial agents and chemotherapy 2005;49(6):2546-9.
2005: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; Silvestri Carmela; Del Prete Maria Simona; Licci Alberto; D'Amato Giuseppina; Lukasiak Jerzy; Scalise Giorgio
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections.
Antimicrobial agents and chemotherapy 2005;49(6):2507-9.
2005: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; D'Amato Giuseppina; Silvestri Carmela; Del Prete Maria Simona; Licci Alberto; Riva Alessandra; Lukasiak Jerzy; Scalise Giorgio
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.
Antimicrobial agents and chemotherapy 2005;49(3):1249-52.
2005: Barchiesi F; Tortorano A M; Di Francesco L Falconi; Rigoni A; Giacometti A; Spreghini E; Scalise G; Viviani M A
Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates.
Journal of medical microbiology 2005;54(Pt 3):279-85.
2005: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; D'Amato Giuseppina; Silvestri Carmela; Del Prete Maria Simona; Licci Alberto; Lukasiak Jerzy; Scalise Giorgio
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.
The Journal of antimicrobial chemotherapy 2005;55(2):272-4.
2005: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Orlando Fiorenza; Kamysz Wojciech; Rocchi Marco; D'Amato Giuseppina; Mocchegiani Federico; Silvestri Carmela; Lukasiak Jerzy; Saba Vittorio; Scalise Giorgio
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Peptides 2005;26(2):207-16.
2005: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Dell'Acqua Giorgio; Orlando Fiorenza; D'Amato Giuseppina; Mocchegiani Federico; Silvestri Carmela; Del Prete Maria Simona; Rocchi Marco; Balaban Naomi; Saba Vittorio; Scalise Giorgio
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Peptides 2005;26(2):169-75.
2004: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Bergnach Cristina; Orlando Fiorenza; D'Amato Giuseppina; Mocchegiani Federico; Silvestri Carmela; Del Prete Maria Simona; Skerlavaj Barbara; Saba Vittorio; Zanetti Margherita; Scalise Giorgio
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Critical care medicine 2004;32(12):2485-90.
2004: Barchiesi Francesco; Maracci Monia; Baldassarri Isabella; Spreghini Elisabetta; Giannini Daniele; Scalise Giorgio
Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
Diagnostic microbiology and infectious disease 2004;50(3):179-85.
2004: Barchiesi Francesco; Spreghini Elisabetta; Baldassarri Isabella; Marigliano Anna; Arzeni Daniela; Giannini Daniele; Scalise Giorgio
Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Antimicrobial agents and chemotherapy 2004;48(10):4056-8.
2004: Barchiesi Francesco; Spreghini Elisabetta; Maracci Monia; Fothergill Annette W; Baldassarri Isabella; Rinaldi Michael G; Scalise Giorgio
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Antimicrobial agents and chemotherapy 2004;48(9):3317-22.
2004: Barchiesi Francesco; Spreghini Elisabetta; Schimizzi Anna M; Maracci Monia; Giannini Daniele; Carle Flavia; Scalise Giorgio
Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
Antimicrobial agents and chemotherapy 2004;48(9):3312-6.
2004: Giacometti Andrea; Ghiselli Roberto; Cirioni Oscar; Mocchegiani Federico; D'Amato Giuseppina; Orlando Fiorenza; Sisti Valerio; Kamysz Wojciech; Silvestri Carmela; Naldoski Piotr; Lukasiak Jerzy; Saba Vittorio; Scalise Giorgio
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
The Journal of antimicrobial chemotherapy 2004;54(3):654-60.
2004: Barchiesi F; Caggiano G; Falconi Di Francesco L; Montagna M T; Barbuti S; Scalise G
Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit.
Diagnostic microbiology and infectious disease 2004;49(4):269-71.
2004: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Orlando Fiorenza; D'Amato Giuseppina; Kamysz Wojciech; Mocchegiani Federico; Sisti Valerio; Silvestri Carmela; Lukasiak Jerzy; Rocchi Marco; Saba Vittorio; Scalise Giorgio
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Antimicrobial agents and chemotherapy 2004;48(8):3162-4.
2004: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; D'Amato Giuseppina; Silvestri Carmela; Simona Del Prete Maria; Lukasiak Jerzy; Scalise Giorgio
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
Diagnostic microbiology and infectious disease 2004;49(3):197-200.
2004: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Orlando Fiorenza; Kamysz Wojciech; D'Amato Giuseppina; Mocchegiani Federico; Lukasiak Jerzy; Silvestri Carmela; Saba Vittorio; Scalise Giorgio
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
The Journal of infectious diseases 2004;190(2):356-64.
2004: Dell'Acqua Giorgio; Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Saba Vittorio; Scalise Giorgio; Gov Yael; Balaban Naomi
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
The Journal of infectious diseases 2004;190(2):318-20.
2004: Balaban Naomi; Gov Yael; Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Mocchegiani Federico; Orlando Fiorenza; D'Amato Giuseppina; Saba Vittorio; Scalise Giorgio; Bernes Sabina; Mor Amram
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci.
Antimicrobial agents and chemotherapy 2004;48(7):2544-50.
2004: Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2004;27(6):603-7.
2004: Ghiselli Roberto; Giacometti Andrea; Cirioni Oscar; Mocchegiani Federico; Orlando Fiorenza; D'Amato Giuseppina; Sisti Valerio; Scalise Giorgio; Saba Vittorio
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
Annals of surgery 2004;239(2):251-6.
2004: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Mocchegiani Federico; D'Amato Giuseppina; Circo Raffaella; Orlando Fiorenza; Skerlavaj Barbara; Silvestri Carmela; Saba Vittorio; Zanetti Margherita; Scalise Giorgio
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.
American journal of respiratory and critical care medicine 2004;169(2):187-94.
2003: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Mocchegiani Federico; Viticchi Claudio; Orlando Fiorenza; D'Amato Giuseppina; Del Prete Maria Simona; Kamysz Wojciech; lLukasiak Jerzy; Saba Vittorio; Scalise Giorgio
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock.
Peptides 2003;24(11):1747-52.
2003: Giacometti Andrea; Ghiselli Roberto; Cirioni Oscar; Mocchegiani Federico; Orlando Fiorenza; Del Prete Maria Simona; D'Amato Giuseppina; Silvestri Carmela; Saba Vittorio; Scalise Giorgio
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
The Journal of antimicrobial chemotherapy 2003;52(4):724-6.
2003: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; D'Amato Giuseppina; Silvestri Carmela; Del Prete Maria Simona; Lukasiak Jerzy; Scalise Giorgio
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Peptides 2003;24(9):1315-8.
2003: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Dell'Acqua Giorgio; Gov Yael; Kamysz Wojciech; Lukasiak Jerzy; Mocchegiani Federico; Orlando Fiorenza; D'Amato Giuseppina; Balaban Naomi; Saba Vittorio; Scalise Giorgio
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Circulation 2003;108(6):767-71.
2003: Giacometti Andrea; Cirioni Oscar; Antonicelli Leonardo; D'Amato Giuseppina; Silvestri Carmela; Del Prete Maria Simona; Scalise Giorgio
Prevalence of intestinal parasites among individuals with allergic skin diseases.
The Journal of parasitology 2003;89(3):490-2.
2003: Ghiselli Roberto; Giacometti Andrea; Cirioni Oscar; Circo Raffaella; Mocchegiani Federico; Skerlavaj Barbara; D'Amato Giuseppina; Scalise Giorgio; Zanetti Margherita; Saba Vittorio
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
Shock (Augusta, Ga.) 2003;19(6):577-81.
2003: Giacometti Andrea; Cirioni Oscar; Gov Yael; Ghiselli Roberto; Del Prete Maria Simona; Mocchegiani Federico; Saba Vittorio; Orlando Fiorenza; Scalise Giorgio; Balaban Naomi; Dell'Acqua Giorgio
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2003;47(6):1979-83.
2003: Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; D'Amato G; Del Prete M Simona; Orlando F; Kamysz W; Lukasiak J; Saba V; Scalise G
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.
Gut 2003;52(6):874-8.
2003: Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; D'Amato G; Silvestri C; Riva A; Del Prete M S; Saba V; Scalise G
Antiendotoxin activity of antimicrobial peptides and glycopeptides.
Journal of chemotherapy (Florence, Italy) 2003;15(2):129-33.
2003: Giacometti Andrea; Cirioni Oscar; Del Prete Maria Simona; Skerlavaj Barbara; Circo Raffaella; Zanetti Margherita; Scalise Giorgio
In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides.
The Journal of antimicrobial chemotherapy 2003;51(4):843-7.
2003: Balaban Naomi; Giacometti Andrea; Cirioni Oscar; Gov Yael; Ghiselli Roberto; Mocchegiani Federico; Viticchi Claudio; Del Prete Maria Simona; Saba Vittorio; Scalise Giorgio; Dell'Acqua Giorgio
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
The Journal of infectious diseases 2003;187(4):625-30.
2003: Barchiesi Francesco; Caggiano Giuseppina; Maracci Monia; Arzeni Daniela; Scalise Giorgio; Montagna Maria Teresa
Antifungal susceptibility patterns of yeast isolates causing bloodstream infections.
The Journal of antimicrobial chemotherapy 2003;51(2):431-3.
2003: Barchiesi Francesco; Milici Maria E; Arzeni Daniela; Schimizzi Anna M; Pizzo Giuseppe; Giammanco Giovanni M; Giannini Daniele; Manfrini Maurizio; Scalise Giorgio; Vicentini Chiara B
In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative.
The Journal of antimicrobial chemotherapy 2003;51(1):167-70.
2002: Barchiesi Francesco; Maracci Monia; Radi Brunella; Arzeni Daniela; Baldassarri Isabella; Giacometti Andrea; Scalise Giorgio
Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.
The Journal of antimicrobial chemotherapy 2002;50(6):999-1002.
2002: Ghiselli Roberto; Giacometti Andrea; Cirioni Oscar; Mocchegiani Federico; Viticchi Claudio; Scalise Giorgio; Saba Vittorio
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model.
The Journal of surgical research 2002;108(1):107-11.
2002: Ghiselli Roberto; Giacometti Andrea; Cirioni Oscar; Mocchegiani Federico; Orlando Fiorenza; Kamysz Wojciech; Del Prete Maria Simona; Lukasiak Jerzy; Scalise Giorgio; Saba Vittorio
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2002;36(5):1027-30.
2002: Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Del Prete M; D'Amato G; Scalise G; Saba V
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2002;24(3):230-4.
2002: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Orlando Fiorenza; Mocchegiani Federico; Riva Alessandra; Del Prete Maria Simona; Saba Vittorio; Scalise Giorgio
Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Antimicrobial agents and chemotherapy 2002;46(9):2885-8.
2002: Giacometti A; Cirioni O; Greganti G; Fineo A; Ghiselli R; Del Prete M S; Mocchegiani F; Fileni B; Caselli F; Petrelli E; Saba V; Scalise G
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(7):553-6.
2002: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Mocchegiani Federico; Del Prete Maria Simona; Viticchi Claudio; Kamysz Wojciech; LEmpicka Elzbieta; Saba Vittorio; Scalise Giorgio
Potential therapeutic role of cationic peptides in three experimental models of septic shock.
Antimicrobial agents and chemotherapy 2002;46(7):2132-6.
2002: Giacometti Andrea; Cirioni Oscar; Kamysz Wojciech; Kasprzykowski Franciszek; Barchiesi Francesco; Del Prete Maria Simona; Mackiewicz Zbigniew; Scalise Giorgio
In vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity.
Peptides 2002;23(5):1015-8.
2002: Pizzo Giuseppi; Barchiesi F; Falconi Di Francesco L; Giuliana G; Arzeni D; Milici M E; D'Angelo M; Scalise G
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
Archives of oral biology 2002;47(3):189-96.
2002: Giacometti Andrea; Cirioni Oscar; Ghiselli Roberto; Mocchegiani Federico; Paggi Alessandra Mataloni; Orlando Fiorenza; Kamysz Wojciech; Kasprzykowski Franciszek; Mackiewicz Zbigniew; Scalise Giorgio; Saba Vittorio
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock.
The Journal of antimicrobial chemotherapy 2002;49(1):193-6.
2002: Cirioni Oscar; Giacometti Andrea; Ghiselli Roberto; Mocchegiani Federico; Fineo Anna; Orlando Fiorenza; Del Prete Maria Simona; Rocchi Marco; Saba Vittorio; Scalise Giorgio
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.
Antimicrobial agents and chemotherapy 2002;46(1):101-4.
2001: Barchiesi F; Schimizzi A M; Caselli F; Giannini D; Camiletti V; Fileni B; Giacometti A; Di Francesco L F; Scalise G
Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 2001;48(6):769-73.
2001: Barchiesi F; Arzeni D; Camiletti V; Simonetti O; Cellini A; Offidani A M; Scalise G
In vitro activity of posaconazole against clinical isolates of dermatophytes.
Journal of clinical microbiology 2001;39(11):4208-9.
2001: Ghiselli R; Giacometti A; Cirioni O; Orlando F; Mocchegiani F; Pacci A M; Scalise G; Saba V
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
The Journal of surgical research 2001;100(2):183-8.
2001: Giacometti A; Cirioni O; Ghiselli R; Viticchi C; Mocchegiani F; Riva A; Saba V; Scalise G
Effect of mono-dose intraperitoneal cecropins in experimental septic shock.
Critical care medicine 2001;29(9):1666-9.
2001: Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi A M; Petrelli E; Scalise G; Saba V
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
The Journal of surgical research 2001;99(2):316-20.
2001: Barchiesi F; Schimizzi A M; Najvar L K; Bocanegra R; Caselli F; Di Cesare S; Giannini D; Di Francesco L F; Giacometti A; Carle F; Scalise G; Graybill J R
Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2001;45(5):1355-9.
2001: Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Riva A; Saba V; Scalise G
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2001;9(1):13-8.
2001: Giacometti A; Cirioni O; Del Prete MS; Barchiesi F; Fineo A; Scalise G
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture.
The Journal of antimicrobial chemotherapy 2001;47(1):97-9.
2001: Barchiesi F; Di Francesco L F; Arzeni D; Caselli F; Simonetti O; Cellini A; Giacometti A; Offidani A M; Scalise G
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections.
Mycopathologia 2001;149(3):117-21.
2000: Ghiselli R; Giacometti A; Goffi L; Cirioni O; Boccoli G; Mocchegiani F; Riva A; Scalise G; Saba V
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2000;20(6):508-11.
2000: Giacometti A; Cirioni O; Del Prete M S; Barchiesi F; Scalise G
Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture.
Antimicrobial agents and chemotherapy 2000;44(12):3473-5.
2000: Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
Antimicrobial agents and chemotherapy 2000;44(12):3306-9.
2000: Giacometti A; Cirioni O; Del Prete M S; Barchiesi F; Paggi A M; Petrelli E; Scalise G
Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
The Journal of antimicrobial chemotherapy 2000;46(5):807-10.
2000: Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis.
The Journal of antimicrobial chemotherapy 2000;46(5):751-6.
2000: Giacometti A; Cirioni O; Barchiesi F; Scalise G
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Diagnostic microbiology and infectious disease 2000;38(2):115-8.
2000: Cirioni O; Giacometti A; Barchiesi F; Scalise G
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline.
The Journal of antimicrobial chemotherapy 2000;46(4):577-82.
2000: Giacometti A; Cirioni O; Ghiselli R; Goffi L; Viticchi C; Mocchegiani F; Riva A; Orlando F; Saba V; Scalise G
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.
Antimicrobial agents and chemotherapy 2000;44(10):2842-4.
2000: Barchiesi F; Schimizzi A M; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco L F; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2000;44(9):2435-41.
2000: Giacometti A; Cirioni O; Del Prete M S; Paggi A M; D'Errico M M; Scalise G
Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria.
Peptides 2000;21(8):1155-60.
2000: Giacometti A; Cirioni O; Del Prete M S; Barchiesi F; Fortuna M; Drenaggi D; Scalise G
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.
Antimicrobial agents and chemotherapy 2000;44(6):1716-9.
2000: Giacometti A; Cirioni O; Barchiesi F; Del Prete M S; Fortuna M; Caselli F; Scalise G
In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically.
Antimicrobial agents and chemotherapy 2000;44(6):1694-6.
2000: Barchiesi F; Calabrese D; Sanglard D; Falconi Di Francesco L; Caselli F; Giannini D; Giacometti A; Gavaudan S; Scalise G
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750.
Antimicrobial agents and chemotherapy 2000;44(6):1578-84.
2000: Giacometti A; Cirioni O; Barchiesi F; Ancarani F; Scalise G
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems.
The Journal of antimicrobial chemotherapy 2000;45(5):651-4.
2000: Giacometti A; Cirioni O; Barchiesi F; Ancarani F; Scalise G
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
The Journal of antimicrobial chemotherapy 2000;45(4):453-6.
2000: Barchiesi F; Arzeni D; Caselli F; Scalise G
Primary resistance to flucytosine among clinical isolates of Candida spp.
The Journal of antimicrobial chemotherapy 2000;45(3):408-9.
2000: Giacometti A; Cirioni O; Barchiesi F; Scalise G
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines.
The Journal of antimicrobial chemotherapy 2000;45(3):375-7.
2000: Giacometti A; Cirioni O; Schimizzi A M; Del Prete M S; Barchiesi F; D'Errico M M; Petrelli E; Scalise G
Epidemiology and microbiology of surgical wound infections.
Journal of clinical microbiology 2000;38(2):918-22.
2000: Lamura L; Matthews R C; Barchiesi F; Donahoe M; Burnie J P; Scalise G
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.
The Journal of infection 2000;40(1):64-8.
2000: Barchiesi F; Arzeni D; Fothergill A W; Di Francesco L F; Caselli F; Rinaldi M G; Scalise G
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens.
Antimicrobial agents and chemotherapy 2000;44(1):226-9.
2000: Giacometti A; Cirioni O; Fortuna M; Osimani P; Antonicelli L; Del Prete M S; Riva A; D'Errico M M; Petrelli E; Scalise G
Environmental and serological evidence for the presence of toxocariasis in the urban area of Ancona, Italy.
European journal of epidemiology 2000;16(11):1023-6.
1999: Giacometti A; Burzacchini F; Cirioni O; Barchiesi F; Dini M; Scalise G
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(12):885-9.
1999: Giacometti A; Cirioni O; Barchiesi F; Fortuna M; Scalise G
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(11):827-9.
1999: Giacometti A; Cirioni O; Barchiesi F; Del Prete M S; Scalise G
Antimicrobial activity of polycationic peptides.
Peptides 1999;20(11):1265-73.
1999: Cirioni O; Giacometti A; Barchiesi F; Fortuna M; Scalise G
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1999;44(5):653-9.
1999: Giacometti A; Cirioni O; Barchiesi F; Fortuna M; Scalise G
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 1999;44(5):641-5.
1999: Di Francesco L F; Barchiesi F; Caselli F; Cirioni O; Scalise G
Comparison of four methods for DNA typing of clinical isolates of Candida glabrata.
Journal of medical microbiology 1999;48(10):955-63.
1999: Giacometti A; Cirioni O; Barchiesi F; Caselli F; Scalise G
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates.
The Journal of antimicrobial chemotherapy 1999;44(3):403-6.
1999: Giacometti A; Cirioni O; Ancarani F; Del Prete M S; Fortuna M; Scalise G
In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Antimicrobial agents and chemotherapy 1999;43(8):2093-6.
1999: Barchiesi F; Gallo D; Caselli F; Di Francesco L F; Arzeni D; Giacometti A; Scalise G
In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 1999;44(1):65-70.
1999: Giacometti A; Cirioni O; Fiorentini A; Fortuna M; Scalise G
Irritable bowel syndrome in patients with Blastocystis hominis infection.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(6):436-9.
1999: Scalise A; Barchiesi F; Viviani M A; Arzeni D; Bertani A; Scalise G
Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot.
The Journal of infection 1999;38(3):191-2.
1999: Cirioni O; Giacometti A; Drenaggi D; Ancarani F; Scalise G
Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts.
European journal of epidemiology 1999;15(4):389-93.
1999: Barchiesi F; Schimizzi A M; Fothergill A W; Scalise G; Rinaldi M G
In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(4):302-4.
1999: Barchiesi F; Falconi Di Francesco L; Arzeni D; Caselli F; Gallo D; Scalise G
Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(3):184-7.
1999: Barchiesi F; Tortorano A M; Di Francesco L F; Cogliati M; Scalise G; Viviani M A
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
The Journal of antimicrobial chemotherapy 1999;43(2):295-9.
1998: Barchiesi F; Arzeni D; Compagnucci P; Di Francesco L F; Giacometti A; Scalise G
In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(6):437-40.
1998: Giacometti A; Cirioni O; Greganti G; Quarta M; Scalise G
In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria.
Antimicrobial agents and chemotherapy 1998;42(12):3320-4.
1998: Giacometti A; Cirioni O; Drenaggi D; Compagnucci P; Quarta M; Fortuna M; Scalise G
Strongyloides stercoralis infection: unknown transmission or late recrudescence?
The Journal of infection 1998;37(3):306-7.
1998: Cirioni O; Giacometti A; Barchiesi F; Scalise G
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1998;42(4):445-51.
1998: Giacometti A; Cirioni O; Quarta M; Schimizzi A M; Del Prete M S; Scalise G
Unusual clinical presentation of infection due to Flavimonas oryzihabitans.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(9):645-8.
1998: Drenaggi D; Cirioni O; Giacometti A; Fiorentini A; Scalise G
Cyclosporiasis in a traveler returning from South America.
Journal of travel medicine 1998;5(3):153-5.
1998: Arzeni D; Barchiesi F; Compagnucci P; Cellini A; Simonetti O; Offidani A M; Scalise G
In vitro activity of terbinafine against clinical isolates of dermatophytes.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(4):235-7.
1998: Cirioni O; Giacometti A; Barchiesi F; Scalise G
In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1998;42(2):141-5.
1998: Tortorano A M; Viviani M A; Barchiesi F; Arzeni D; Rigoni A L; Cogliati M; Compagnucci P; Scalise G
Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients.
Journal of clinical microbiology 1998;36(6):1578-83.
1998: Offidani A; Simoncini C; Arzeni D; Cellini A; Amerio P; Scalise G
Tinea capitis due to Microsporum gypseum in an adult.
Mycoses 1998;41(5-6):239-41.
1998: Barchiesi F; Arzeni D; Del Prete M S; Sinicco A; Falconi Di Francesco L; Pasticci M B; Lamura L; Nuzzo M M; Burzacchini F; Coppola S; Chiodo F; Scalise G
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
The Journal of antimicrobial chemotherapy 1998;41(5):541-8.
1998: Barchiesi F; Di Francesco L F; Compagnucci P; Arzeni D; Giacometti A; Scalise G
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
The Journal of antimicrobial chemotherapy 1998;41(1):59-65.
1997: Giacometti A; Cirioni O; Balducci M; Drenaggi D; Quarta M; De Federicis M; Ruggeri P; Colapinto D; Ripani G; Scalise G
Epidemiologic features of intestinal parasitic infections in Italian mental institutions.
European journal of epidemiology 1997;13(7):825-30.
1997: Cirioni O; Giacometti A; Quarta M; Scalise G
In-vitro activity of topoisomerase inhibitors against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1997;40(4):583-6.
1997: Barchiesi F; Di Francesco L F; Compagnucci P; Arzeni D; Cirioni O; Scalise G
Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(8):601-5.
1997: Barchiesi F; Falconi Di Francesco L; Scalise G
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Antimicrobial agents and chemotherapy 1997;41(8):1812-4.
1997: Arzeni D; Del Poeta M; Simonetti O; Offidani A M; Lamura L; Balducci M; Cester N; Giacometti A; Scalise G
Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.
European journal of epidemiology 1997;13(4):447-50.
1997: Giacometti A; Cirioni O; Burzacchini F; Del Prete M S; Balducci M; al Natour I; Scalise G
Rhodococcus equi infections: antibiotic therapy and relapses.
AIDS (London, England) 1997;11(1):120-1.
1997: Cirioni O; Giacometti A; Scalise G
In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1997;39(1):45-51.
1996: Giacometti A; Cirioni O; Scalise G
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.
The Journal of antimicrobial chemotherapy 1996;38(3):399-408.
1996: Cirioni O; Giacometti A; Burzacchini F; Balducci M; Scalise G
Strongyloides stercoralis first-stage larvae in the lungs of a patient with AIDS: primary localization or a noninvasive form of dissemination?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(4):737.
1995: Giacometti A; Del Prete M S; Cirioni O; Izat M K; Balducci M; Cesarini A M; Scalise G
Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa.
Journal of chemotherapy (Florence, Italy) 1995;7 Suppl 4():76-7.
1995: Cirioni O; Giacometti A; Balducci M; Burzacchini F; Scalise G
In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii.
The Journal of antimicrobial chemotherapy 1995;36(4):740-2.
1995: Cirioni O; Giacometti A; Balducci M; Drenaggi D; Del Prete M S; Scalise G
Anticryptosporidial activity of paromomycin.
The Journal of infectious diseases 1995;172(4):1169-70.
1995: Mocchegiani E; Veccia S; Ancarani F; Scalise G; Fabris N
Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS.
International journal of immunopharmacology 1995;17(9):719-27.
1995: Barchiesi F; Hollis R J; Del Poeta M; McGough D A; Scalise G; Rinaldi M G; Pfaller M A
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):561-4.
1995: Barchiesi F; Hollis R J; McGough D A; Scalise G; Rinaldi M G; Pfaller M A
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(3):634-40.
1995: Bagnarelli P; Menzo S; Valenza A; Paolucci S; Petroni S; Scalise G; Sampaolesi R; Manzin A; Varaldo P E; Clementi M
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.
Journal of clinical microbiology 1995;33(1):16-23.
1994: Del Poeta M; Barchiesi F; Arzeni D; Marinucci G; Scalise G
Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.
Mycoses 1994;37(11-12):411-6.
1994: Piersimoni C; Bornigia S; De Sio G; Scalise G
Bacteriostatic and bactericidal activities of paromomycin against Mycobacterium avium complex isolates.
The Journal of antimicrobial chemotherapy 1994;34(3):421-4.
1994: Del Poeta M; Barchiesi F; Morbiducci V; Arzeni D; Marinucci G; Ancarani F; Scalise G
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Journal of chemotherapy (Florence, Italy) 1994;6(3):173-6.
1994: Barchiesi F; Del Poeta M; Morbiducci V; Ancarani F; Scalise G
Effect of pentamidine on the growth of Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 1994;33(6):1229-32.
1994: Giacometti A; Siquini F M; Cirioni O; Petroni S; Scalise G
Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(4):315-8.
1994: Bagnarelli P; Valenza A; Menzo S; Manzin A; Scalise G; Varaldo P E; Clementi M
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo.
Journal of virology 1994;68(4):2495-502.
1993: Arzese A; Pipan C; Piersimoni C; Scalise G; Morbiducci V; Botta G A
Characterization of mesophilic Aeromonas from clinical specimens by computerized analysis of SDS-PAGE protein profiles and by enzymatic activity.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 1993;16(4):333-42.
1993: Barchiesi F; Del Poeta M; Morbiducci V; Ancarani F; Scalise G
Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.
Mycopathologia 1993;124(1):19-25.
1993: Barchiesi F; Morbiducci V; Ancarani F; Scalise G
Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients.
European journal of epidemiology 1993;9(4):455-6.
1993: Barchiesi F; Morbiducci V; Ancarani F; Arzeni D; Scalise G
Trichosporon beigelii fungaemia in an AIDS patient.
AIDS (London, England) 1993;7(1):139-40.
1992: Bagnarelli P; Menzo S; Valenza A; Manzin A; Giacca M; Ancarani F; Scalise G; Varaldo P E; Clementi M
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.
Journal of virology 1992;66(12):7328-35.
1992: Piersimoni C; Morbiducci V; Bornigia S; De Sio G; Scalise G
In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
The American review of respiratory disease 1992;146(6):1445-7.
1992: Piersimoni C; Morbiducci V; De Sio G; Scalise G
Comparative evaluation of the MB-Check system for recovery of mycobacteria from clinical specimens.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(12):1174-7.
1992: Barchiesi F; Giacometti A; Arzeni D; Branchesi P; Crescenzi G; Ancarani F; Scalise G
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Journal of chemotherapy (Florence, Italy) 1992;4(6):381-6.
1992: Mocchegiani E; Scalise G; Veccia S; Fabris N
Zinc-dependent thymic hormone failure in AIDS.
Annals of the New York Academy of Sciences 1992;650():94-8.
1991: Piersimoni C; Felici L; Giorgi P; Morbiducci V; Scalise G
Mixed mycobacterial infection of cervical lymph nodes.
The Pediatric infectious disease journal 1991;10(7):544-5.
1991: Drenaggi D; Petrelli E; Cagnoni G; Ancarani F; Agostinelli M; Giacometti A; Scalise G
Therapy with immunoglobulin of the HIV infection related idiopathic thrombocytopenia.
Allergologia et immunopathologia 1991;19(4):157-9.
1991: Arzeni D; Barchiesi F; Ancarani F; Scalise G
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
Journal of chemotherapy (Florence, Italy) 1991;3(3):139-42.
1991: Piersimoni C; Morbiducci V; Scalise G
Non-O1 Vibrio cholerae gastroenteritis and bacteraemia.
Lancet 1991;337(8744):791-2.
1991: Giacometti A; Fiorentini A; Mazzoccanti M R; Mengoni S; Petroni S; Scalise G
Epidemiological surveillance of staphylococcal resistance.
Journal of chemotherapy (Florence, Italy) 1991;3 Suppl 1():163-5.
1991: Giacometti A; Branchesi P; Corbelli G; Fiorentini A; Petroni S; Scalise G
[Routine isolation of mutants resistant to beta-lactams among gram-negative microorganisms]
Giornale italiano di chemioterapia 1991;38(1-3):149-50.
1990: Giacometti A; Pongetti P; Petrelli E; Scalise G
Imipenem/cilastatin treatment of acute infections in AIDS/ARC patients.
Journal of chemotherapy (Florence, Italy) 1990;2(4):247-51.
1990: Piersimoni C; Morbiducci V; De Sio G; Scalise G
Rapid presumptive phenospecies identification of mesophilic aeromonads by testing for suicidal activity.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(8):608-10.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Giorgio Scalise

Research Profile (preview)

Procedures

Chemicals & Drugs

Living Beings

Disorders

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Giorgio Scalise (preview)

All Publications